Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
European Journal of Medicinal Chemistry|May 17, 2023
Inside PD-1/PD-L1,2 with their inhibitorsNicolas Boisgerault, Philippe BertrandOncoimmunology|October 24, 2014
Trick and treat: Ambushing recurrent tumors before they get out of the doorNicolas Boisgerault, Richard G VileImmunotherapy|July 20, 2010
New perspectives in cancer virotherapy: bringing the immune system into playNicolas Boisgerault, Frédéric Tangy, Marc GregoireVirologie (Montrouge, France)|August 18, 2025
[Antitumor immuno-virotherapy with attenuated strains of measles virus]Jean-François Fonteneau, Nicolas Boisgerault, Frédéric TangyEuropean Journal of Medicinal Chemistry|March 13, 2010
Inside HDAC with HDAC inhibitorsPhilippe BertrandJournal of Medicinal Chemistry|August 10, 2023
Aptamers Targeting the PD-1/PD-L1 Axis: A PerspectivePhilippe BertrandCancer Research|June 19, 2008
Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 responseAnne Gauvrit, Samantha Brandler, Carole Sapede-Peroz, et al.Molecular Cancer|March 25, 2021
Delivery of cancer therapies by synthetic and bio-inspired nanovectorsTina Briolay, Tacien Petithomme, Morgane Fouet, et al.Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell DeathTiphaine Delaunay, Carole Achard, Marc Grégoire, et al.RSC Advances|July 12, 2023
Convergent micro-wave assisted synthesis of quinazolinone and its precursor using the bio-sourced solvent pinaneAntoine Richieu, Philippe BertrandPageof 15